Navigation Links
Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
Date:8/5/2008

Clinical study planned for advanced or recurrent solid tumors

PRINCETON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today the allowance of an investigational new drug application (IND) filed with the U.S. Food & Drug Administration (FDA) for MDX-1105, for the treatment of patients with selected advanced or recurrent solid tumors, specifically renal cell carcinoma, melanoma, non-small cell lung cancer or epithelial ovarian cancer. MDX-1105 is a fully human antibody that targets the PD-L1 pathway to promote enhanced T-cell immune responses against cancer and reverse T-cell inactivation in chronic infectious disease.

The open-label, multi-dose, dose-escalation Phase 1 clinical trial is expected to enroll up to 46 patients with selected advanced or recurrent solid tumors. This trial is designed to establish and evaluate the safety, tolerability and maximum tolerated dose, as well as preliminary pharmacodynamics and efficacy, of MDX-1105.

"We are pleased that another product candidate from our proprietary pipeline has progressed into clinical trials," said Howard H. Pien, President and CEO of Medarex. "We believe that our fully human anti-PD-1 and anti-PD-L1 antibodies represent the next stage in immunotherapy beyond the anti-CTLA-4 antibodies. We look forward to exploring the potential of MDX-1105 as a possible new treatment option for patients with cancer and infectious disease."

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
7. Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...e/ -- Reportlinker.com announces that a new market..., Global Markets for Assisted Reproductive Devi...4742/Global-Markets-for-Assisted-Reproductive-Devi...=pr&utm_campaign=prnewswire ,, Global Mar... Countries in Europe and Japan. This report includ...
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...swire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin ...known as DOR BioPharma, Inc., a late-stage biotech... a consortium to develop thermostable technology t...nes. Soligenix received a $9.4 million grant from ...iseases (NIAID), a division of the National Instit...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Blue Shield of California Expands CalPERS NetValue Service Area 52337 1Blue Shield of California Expands CalPERS NetValue Service Area 52337 2Blue Shield of California Expands CalPERS NetValue Service Area 52337 3Free Drug Card Has Saved Washington Residents 242 6 Million 52334 1Free Drug Card Has Saved Washington Residents 242 6 Million 52334 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 1Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 2Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 3Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 4Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 5Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 6Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 7Young Innovations Inc Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program 52330 8
... of mature dendritic cells with tumor lysate,trigg...SBURG, Md., and YOKOHAMA, Japan, June 22, 2007,/PR...nnounce a,joint poster presentation at the 13th An...ular Therapy. The meeting is being,held June 24-27... entitled "Electroloading of mature dendritic,cell...
...--(BUSINESS WIRE)--Jun 21, 2007 - Advanced Cell,Te...uced a human,embryonic stem cell (hESC) line witho...assachusetts. This development was announced by,Ro...Development of,Advanced Cell Technology (ACT) on T...ional Society for Stem Cell Research (ISSCR),in Ca...
Other Medicine Technology:MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 2Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 3
(Date:11/21/2009)... Eric J. Hall, president and chief executive off...) issued the following statement regarding the inc...f the new annual wellness for Medicare beneficiari...Care Act" that was introduced last night: , ...ber 21, 2009 -- Eric J. Hall, president and chief ...
(Date:11/20/2009)...NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharm...eting of Shareholders will be held on Monday, Dece...nsider approval of two special resolutions. The fi... the sale of all or substantially all of the asset...for in the asset purchase agreement dated November...
(Date:11/20/2009)... Senators and Congressmen in Competitive Re-elec... Care Vote , Washington, ...essmen running for re-election next year in races ... Cook, may come to regret voting for House Speaker...to a breaking Zogby International/ O’Leary R...
(Date:11/20/2009)..., Israel, November 20 Ca...p://www.CVSLMEDICAL.COM , a leading,developer of a...nnounced that,the company,s Board of Directors has..., Canada and the Far East for its proprietary next...ll angioplasty (PCTA) procedures. , Cardi...
(Date:11/20/2009)...d online November 20 in the Journal of the Nation...rs and hopes that often appear in news coverage of...for both the media and journals to help alleviate ... Steven Woloshin, M.D., M.S., of Center for Medici...alth Policy and Clinical Practice in New Hampshire...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...SING, Mich., Feb. 3 Cherries are not only good fo...per Fruit." According to recent,data, more than 9 ...comes,from, nearly 80 percent say they,re purchasi...f cherries consumed in the U.S. are grown here,wit...
...A BEACH, Va., Feb. 3, 2009 AMERIGROUP Corporation...y, Esq., MPH has been named Chief Compliance Offic...l Company operations comply with state and federal...ties at AMERIGROUP," said John E. Littel, AMERIGRO...
...NCISCO, Feb. 3 Nile Therapeutics, Inc., (Nasdaq: ...f Executive Officer, will present a corporate over...ference in New York. The presentation will take pl...linical-stage biopharmaceutical company that devel...
...MI, Feb. 3 Baker & McKenzie, and Bankstreet G...mit aimed at informing investors,in the healthcare...y 12th at,the Harvard Club. , Internationally ...of Miami and Palm Beach, Florida,( http://www.mors...
...will provide web foundation for the newly launched...., Feb. 3 Univita Health, a new company aimed at ...to independent aging, announced the acquisition of...eation of a virtual marketplace for individuals to...
...FANG, Shandong, China, Feb. 3 /PRNewswire-Asia-Fir...etin Board: SGTI) ("Shengtai Pharmaceutical" or,"t...or of high-quality,pharmaceutical grade glucose pr...ence. , This conference will be held from Mond...
Other Medicine News:Health News:Cherries: 'America's Super Fruit' Offers Homegrown Health Benefits 2Health News:Cherries: 'America's Super Fruit' Offers Homegrown Health Benefits 3Health News:AMERIGROUP Names Finley Chief Compliance Officer 2Health News:Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference 2Health News:James G. Schwade, M.D. to Deliver Keynote Address to Financial and Investment Industry in New York 2Health News:Univita Health Acquires Leading Web Services Company 2Health News:Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference 2Health News:Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference 3
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: